Bone Health and Oral Beauty Drive China's Supplement Boom

Executive Summary

China's online health supplements market reached CN¥ 115.45 billion in 2023 (+24.6% YoY), but the headline growth masks a structural divergence among sub-segments that reveals where the real opportunities lie. Bone health surged +34.5% YoY to CN¥ 9.09 billion --- propelled by youth height-growth products and lysine-based formulations --- while the oral beauty segment contracted -15.3% to CN¥ 9.75 billion even as its collagen sub-category grew +27.5% to CN¥ 3.13 billion. For brands and investors evaluating China's supplement landscape, these three segments illustrate how ingredient innovation, demographic targeting, and regulatory shifts are rewriting the competitive playbook.

Bone Health: The Segment That Keeps Accelerating

Bone health is no longer a slow-and-steady calcium story. The segment reached CN¥ 9.09 billion on the Taobao ecosystem in 2023, and what makes its +34.5% YoY growth rate notable is the acceleration: growth climbed from +17.2% in 2021 to +26.9% in 2022 and then +34.5% in 2023, defying the typical pattern of deceleration as categories scale.

Two demand drivers explain this trajectory. First, youth height-growth products have emerged as a premium sub-category that did not meaningfully exist three years ago. Parents seeking supplements to support their children's growth development have embraced lysine-based formulations, pushing the CN¥ 500+ price tier from 10.2% to 27.9% of segment sales. Brands including Hamiher, allnature, and Aismun (爱司盟) have built strong positions in this premium tier. Second, cross-border channels more than doubled from CN¥ 2.02 billion in 2021 to CN¥ 4.22 billion in 2023, as consumers gravitated toward US-origin products whose market share rose from 21.0% to 34.3%.

Consumer review data from Tmall confirms the bimodal demand structure. Children and adolescents account for 53.5% of demographic mentions in bone health reviews, while middle-aged and elderly consumers represent 34.5%. Calcium supplementation (30.5% of scenario mentions) remains the baseline need across all age groups, but joint and knee pain (21.6%) and growing taller (11.6%) reveal the segment's expanding functional scope.

The ingredient landscape tells the most dramatic story. Calcium remains the foundation at CN¥ 6.86 billion, but the fastest-growing ingredients are redefining the category. Lysine sales reached CN¥ 2.28 billion with +278.3% YoY growth, establishing it as the second-largest ingredient by revenue. Hydrolyzed egg yolk powder grew more than 22-fold YoY, driven almost entirely by allnature's Growth Tech product line that combines hydrolyzed egg yolk with GABA to target adolescent sleep and height growth simultaneously. Vitamin K also surged +134.8% YoY as clinical recognition of its role in directing calcium to bones rather than soft tissues widened consumer awareness. The shift from simple single-ingredient calcium tablets toward complex, multi-ingredient formulations marks a maturation point for the segment.

Bone health market accelerates to +34.5% YoY growth in 2023

Oral Beauty: Contraction Masks a Collagen Bright Spot

The oral beauty segment tells a more complex story. After peaking at CN¥ 11.50 billion in 2022, it fell -15.3% to CN¥ 9.75 billion in 2023 --- below even the 2021 level of CN¥ 9.84 billion. Consumer fatigue with undifferentiated beauty supplements, tightened regulatory scrutiny of health claims, and scattered negative publicity around adverse reactions all contributed to the downturn.

Yet the aggregate decline obscures an important structural shift. Domestic Chinese brands are gaining ground rapidly, with Mainland China-origin products increasing share by +10.6 percentage points to 26.6% in 2023, while US-origin products fell from 47.4% to 33.0%. Domestic trade channel sales reached CN¥ 4.85 billion, as brands like Five Female PhDs (五个女博士) establish credibility through transparent ingredient sourcing and efficacy evidence. Meanwhile, Tmall Global cross-border sales cratered from CN¥ 4.68 billion to CN¥ 2.40 billion --- the largest absolute decline in any health supplement sales channel.

The takeaway is clear: consumers are not abandoning oral beauty. They are concentrating purchases on products with stronger evidence bases and more transparent ingredient narratives, and increasingly choosing domestic brands that compete on innovation rather than origin-country prestige. Japan-origin products also lost ground, declining from 11.5% share in 2021 to 7.8% in 2023, while New Zealand grew modestly from 5.1% to 7.5%, buoyed by the country's clean-ingredient reputation.

Collagen Deep Dive: PQQ, Innovation Ingredients, and Premiumization

Collagen is the clearest beneficiary of oral beauty's flight to quality. The sub-segment reached CN¥ 3.13 billion in 2023 (+27.5% YoY), and its share of the oral beauty market jumped from 20.9% in 2021 to 32.1% in 2023. Domestic brands dominate, with Mainland China-origin products holding 55.8% market share and the domestic trade channel accounting for CN¥ 2.66 billion of total collagen sales.

On the ingredient innovation front, PQQ (pyrroloquinoline quinone disodium salt) has emerged as the dominant supplementary ingredient in collagen formulations, achieving CN¥ 970 million in sales (+74.8% YoY). PQQ's trajectory received a decisive boost when China's National Health Commission officially approved it as a new food ingredient in October 2023, removing a key barrier to product formulation and marketing claims. White tomato, promoted for melanin inhibition and skin-brightening effects, grew even faster at +80.3% YoY, while bird's nest maintained CN¥ 418 million in sales by combining traditional Chinese luxury appeal with modern collagen science.

Premiumization is evident throughout the collagen segment. The CN¥ 600-900 price range grew +112.4% in sales revenue YoY, while the CN¥ 900-1,200 range surged +110.7%, as consumers increasingly adopt course-based purchasing models that commit to multi-month supplementation programs. Popular mid-range brands in the CN¥ 300-600 tier include Filide (斐利德), Five Female PhDs, Swisse, and By-Health (汤臣倍健). Notably, the ultra-premium CN¥ 1,200+ tier contracted -28.4%, suggesting that extreme premiumization without commensurate differentiation is being rejected. Consumer motivations are strongly lifestyle-driven: sleep concerns and staying up late together account for 62.3% of collagen consumption scenario mentions in Tmall reviews, creating a natural bridge between beauty and wellness positioning. This sleep-beauty connection opens formulation opportunities for products combining collagen with sleep-quality ingredients such as GABA or magnesium.

PQQ leads collagen supplementary ingredients at CN¥ 970 million

Key Takeaways

• Bone health is the standout growth segment. At CN¥ 9.09 billion (+34.5% YoY) with an accelerating growth curve, it offers the strongest combination of market scale and momentum in China's supplements landscape.
• Youth height-growth products are reshaping the bone health category. Lysine (+278.3% YoY) and hydrolyzed egg yolk powder (22x YoY growth) are driving premiumization, with the CN¥ 500+ price tier nearly tripling its share to 27.9%.
• Oral beauty's -15.3% decline is a flight to quality, not a category exit. Collagen grew +27.5% within the declining market, reaching 32.1% segment share, as consumers concentrate spending on evidence-based products.
• PQQ is the ingredient to watch in collagen. Regulatory approval in October 2023 catalyzed CN¥ 970 million in sales (+74.8% YoY), making it the leading supplementary ingredient in collagen formulations.
• Domestic brands are winning the oral beauty battle. Chinese-origin oral beauty products gained +10.6 percentage points of market share in a single year, while US-origin share dropped -14.4 points, signaling a structural shift toward locally-driven innovation.

About the Data

This analysis is based on Moojing Market Intelligence data covering China's major e-commerce platforms including Taobao (淘宝), Tmall (天猫), JD.com (京东), and Douyin (抖音) for the period Q2 2024.